These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 26773436)
1. Conversion of Prostate Adenocarcinoma to Small Cell Carcinoma-Like by Reprogramming. Borges GT; Vêncio EF; Quek SI; Chen A; Salvanha DM; Vêncio RZ; Nguyen HM; Vessella RL; Cavanaugh C; Ware CB; Troisch P; Liu AY J Cell Physiol; 2016 Sep; 231(9):2040-7. PubMed ID: 26773436 [TBL] [Abstract][Full Text] [Related]
2. Lineage relationship between prostate adenocarcinoma and small cell carcinoma. Kanan AD; Corey E; Vêncio RZN; Ishwar A; Liu AY BMC Cancer; 2019 May; 19(1):518. PubMed ID: 31146720 [TBL] [Abstract][Full Text] [Related]
3. The opposing action of stromal cell proenkephalin and stem cell transcription factors in prostate cancer differentiation. Liu AY BMC Cancer; 2021 Dec; 21(1):1335. PubMed ID: 34911496 [TBL] [Abstract][Full Text] [Related]
5. Lineage relationship of prostate cancer cell types based on gene expression. Pascal LE; Vêncio RZ; Vessella RL; Ware CB; Vêncio EF; Denyer G; Liu AY BMC Med Genomics; 2011 May; 4():46. PubMed ID: 21605402 [TBL] [Abstract][Full Text] [Related]
6. Reprogramming of prostate cancer-associated stromal cells to embryonic stem-like. Vêncio EF; Nelson AM; Cavanaugh C; Ware CB; Milller DG; Garcia JC; Vêncio RZ; Loprieno MA; Liu AY Prostate; 2012 Sep; 72(13):1453-63. PubMed ID: 22314551 [TBL] [Abstract][Full Text] [Related]
7. In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors. Wu JD; Odman A; Higgins LM; Haugk K; Vessella R; Ludwig DL; Plymate SR Clin Cancer Res; 2005 Apr; 11(8):3065-74. PubMed ID: 15837762 [TBL] [Abstract][Full Text] [Related]
8. Cancer-secreted AGR2 induces programmed cell death in normal cells. Vitello EA; Quek SI; Kincaid H; Fuchs T; Crichton DJ; Troisch P; Liu AY Oncotarget; 2016 Aug; 7(31):49425-49434. PubMed ID: 27283903 [TBL] [Abstract][Full Text] [Related]
9. Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancer. Valta MP; Zhao H; Saar M; Tuomela J; Nolley R; Linxweiler J; Sandholm J; Lehtimäki J; Härkönen P; Coleman I; Nelson PS; Corey E; Peehl DM Clin Exp Metastasis; 2016 Apr; 33(4):325-37. PubMed ID: 26873136 [TBL] [Abstract][Full Text] [Related]
11. Prostate cancer research: tools, cell types, and molecular targets. Liu AY Front Oncol; 2024; 14():1321694. PubMed ID: 38595814 [TBL] [Abstract][Full Text] [Related]
12. Reprogramming of prostate cancer cells--technical challenges. Borges GT; Vêncio EF; Vêncio RZ; Vessella RL; Ware CB; Liu AY Curr Urol Rep; 2015 Jan; 16(1):468. PubMed ID: 25404182 [TBL] [Abstract][Full Text] [Related]
13. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency. Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786 [TBL] [Abstract][Full Text] [Related]
14. WISH-PC2: a unique xenograft model of human prostatic small cell carcinoma. Pinthus JH; Waks T; Schindler DG; Harmelin A; Said JW; Belldegrun A; Ramon J; Eshhar Z Cancer Res; 2000 Dec; 60(23):6563-7. PubMed ID: 11118033 [TBL] [Abstract][Full Text] [Related]
15. A novel mechanism of SRRM4 in promoting neuroendocrine prostate cancer development via a pluripotency gene network. Lee AR; Gan Y; Tang Y; Dong X EBioMedicine; 2018 Sep; 35():167-177. PubMed ID: 30100395 [TBL] [Abstract][Full Text] [Related]
16. Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature. Labrecque MP; Brown LG; Coleman IM; Nguyen HM; Lin DW; Corey E; Nelson PS; Morrissey C PLoS One; 2021; 16(1):e0245602. PubMed ID: 33471819 [TBL] [Abstract][Full Text] [Related]
17. Establishment and serial passage of cell cultures derived from LuCaP xenografts. Young SR; Saar M; Santos J; Nguyen HM; Vessella RL; Peehl DM Prostate; 2013 Sep; 73(12):1251-62. PubMed ID: 23740600 [TBL] [Abstract][Full Text] [Related]
18. Expression analysis of putative stem cell markers in human benign and malignant prostate. Ugolkov AV; Eisengart LJ; Luan C; Yang XJ Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131 [TBL] [Abstract][Full Text] [Related]